Hematólogos crean el primer Comité de Mieloma Múltiple en México
El objetivo del proyecto es lograr la estandarización para el tratamiento médico de pacientes con mieloma múltiple en México.
Related Articles
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Read it now on PracticeUpdate.com
Mexico’s Irresponsible Populist President Proposes Election-Year Giveaway
I’ve written many columns about Venezuela, Chile, and Argentina, but only one column specifically about Mexico. Since I’m currently in Mexico City doing some meetings…
Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy
Radiation therapy (RT) may play an important role prior to and following BCMA-targeted CAR T-cell therapy in multiple myeloma (MM). We report a series…
Genomic Classification and Individualized Prognosis in Multiple Myeloma
Read it now on PracticeUpdate.com
Genomic Classification and Individualized Prognosis in Multiple Myeloma
Read it now on PracticeUpdate.com
Incidence or T cell lymphoma in patients diagnosed with multiple myeloma or diffuse large B-cell lymphoma
A Komodo Real World Evidence analysis
Incidence or T cell lymphoma in patients diagnosed with multiple myeloma or diffuse large B-cell lymphoma
A Komodo Real World Evidence analysis
Incidence or T cell lymphoma in patients diagnosed with multiple myeloma or diffuse large B-cell lymphoma
A Komodo Real World Evidence analysis
Real-World Clinical Equivalence of Generic and Branded Tofacitinib: A Prospective Longitudinal Cohort Study in Patients With Rheumatoid Arthritis
To explore the clinical efficacy and safety of generic tofacitinib vs brand name tofacitinib in patients with rheumatoid arthritis (RA) in a single-ce…